Quality & Profitability for Your PracticeLearn actionable strategies to expand your offerings, enhance retention, and boost revenue by integrating peptide therapies
Nat Rev Drug Discov, 2013
Take care of your mental health : High stress levels can impede GLP-1 production and make it harder to shift excess weight
Diabetes Care 46 , 10051013 (2023)
While both GLP-1 medications and post-cholecystectomy digestion can involve gastrointestinal symptoms like nausea, diarrhea, or constipation, these dont typically worsen pre-existing post-cholecystectomy issues
Food and Drug Administration cleared Ascletis Pharma to start a Phase 1 clinical trial of ASC35 , a once-monthly subcutaneous peptide that activates both the GLP-1 and GIP receptors